Accuprec Research Labs Pvt Ltd will participate in 15th BioAsia scheduled from Feb 22-24, 2018 at HICC Hyderabad and will get a chance to present in front of over 1500 delegates from over 50 countries. Government of Gujarat is the state partner in the mega event.
In India’s bid to tackle unaffordable healthcare arises a need to create a globally competitive life sciences ecosystem for start ups. With about 500 start-ups as on date in the healthcare space and the announcement of "Innovate in India" initiative, India is all set to capitalize on the next big global opportunity in healthcare.Under this context, BioAsia 2018 will prove to be vital platform for the 'out-of-the-box' developers and founders who are contributing in transformation of the Biotech/healthcare arena in the country. Handpicked ideas and growth stage startups will be showcased during the exhibition. Accuprec will participate in the startup category.
Shri Suresh Prabhu, Union Minister of Commerce & Induatry will chair the BioAsia 2018 CEO Conclave deliberations.Mrs. Kiran Mazumdar-Shaw, Chairman & MD Biocon Ltd, Mr. Satish Reddy, Chairman of Dr. Reddy's Laboratories Ltd, Dr. Sudhir Kumar Singh, President, Discovery & Development GVK BIO, Mr. Gerald Heddell, Director, Inspection Enforcement & Standards Division, MHRA, UK, Mr. Lucas Sigman, Managing Director, Chemo Group, Switzerland will be the esteemed speakers. Dr. Shreeram Aradhye (CMO Novartis), Mr. Partha Dey (Healthcare Leader, IBM India/South Asia), Mr. Satish Reddy (Chairman, Dr. Reddy’s), Mr. Daniel Mazon (VC & MD, Philips India), Mr. Pankaj Sahni (COO, Medanta Medicity), Dr. Letitia Robinson (Director, U.S. FDA, India), etc. and VCs like Mr. Milind Shah (Venture Partner, Unitus Seed Fund), Mr. Vishal Bali (Co-founder & Chairman of Medwell Ventures & Asia Head – Healthcare, TPG Growth), Dr. Nalini Tandon (Founder & CEO, Tenacity Global Group Inc., Silicon Valley, USA), Mr. Deepak Gaur (SAIF Partners), Mr. Virendra Pandey (Director & Head, Healthcare & Lifesciences, Investment Banking, Spark Capital Advisors), among others have confirmed their participation. Dr Letitia Robinson, Director, USFDA, India office, Mr. Sanjiv Navangul, MD, Janssen Pharmaceuticals, Mr. Greg Reh, Vice Chairman, US & Global Life Sciences, Dr. Udit Batra, Member of the Executive Board, CEO Life Science, Merck, USA will also be on panel of speakers.